Inventor · Cachan, FR

Daniel Ladant

14Patents
6h-index
27Co-inventors
66Inventor score

Filing activity: Oct 25, 1989 → Jun 8, 2016

Most-cited inventions

PatentTitleAreaCited byStatus
US6333154A Bacterial multi-hybrid system and applications thereof Physics 29 Expired
US5503829A Recombinant mutants for inducing specific immune responses Emerging Cross-Sectional Technologies 17 Expired
US5183745A Adenyl cyclase derivatives and their biological uses Human Necessities 14 Expired
US5935580A Recombinant mutants for inducing specific immune responses Emerging Cross-Sectional Technologies 12 Expired
US5679784A Recombinant mutants for inducing specific immune responses Emerging Cross-Sectional Technologies 6 Expired
US8628779B2 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof Chemistry; Metallurgy 6 Active
US7906123B1 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof Human Necessities 4 Active
US8637039B2 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof Chemistry; Metallurgy 4 Active
US9410139B2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens Mechanical Engineering; Lighting; Heating 2 Active
US9370564B2 Vectors for molecule delivery to CD11b expressing cells Emerging Cross-Sectional Technologies 1 Active
US9387243B2 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof Chemistry; Metallurgy 0 Active
US10760072B2 In vivo detection of proteins interaction based on adenylate cyclase hybrid system Physics 0 Active
US10920212B2 Monomeric and functional adenylate cyclase CyaA toxin Chemistry; Metallurgy 0 Active
US10004794B2 Vectors for molecule delivery to CD11b expressing cells Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.